Sales Success Comes With Side Effects For Drug Maker BeiGene


Red capsules. Medicine. The science. Pills for diseases.

okskaz/iStock via Getty Images

China’s BeiGene Ltd. (6160.HK; 688235.SH; NASDAQ:BGNE) has underlined its status as a rising star of the global drugs industry, posting a big jump in quarterly sales of its trademark cancer medicines.

But the upstart drug



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *